Palivizumab is used to treat respiratory syncytial virus disease. This antiviral drug is a(n)
A) immunosuppressive.
B) monoclonal antibody.
C) toxoid.
D) nucleoside analog.
E) vaccine.

Question

Quizplus · Accepted Answer

Palivizumab is a monoclonal antibody used to prevent respiratory syncytial virus (RSV) infections, particularly in high-risk infants. It is not an immunosuppressive, toxoid, nucleoside analog, or vaccine.

Palivizumab Is Used to Treat Respiratory Syncytial Virus Disease